|
A novel approach for clustering proteomics data using Bayesian fast Fourier transform.
|
15769836
|
Bioinformatics
|
|
A novel approach toward development of a rapid blood test for breast cancer.
|
14499014
|
Clin. Breast Cancer
|
|
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
|
17981926
|
Clin. Chem.
|
|
Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer.
|
16552720
|
J. Cell. Biochem.
|
|
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.
|
12324514
|
Clin. Chem.
|
|
Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.
|
29330297
|
Mol. Cancer Res.
|
|
Clinical proteomics: A need to define the field and to begin to set adequate standards.
|
21136664
|
Proteomics Clin Appl
|
|
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status.
|
14997503
|
Proteomics
|
|
Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data.
|
12762451
|
Biometrics
|
|
Deconvolution filters to enhance resolution of dense time-of-flight survey spectra in the time-lag optimization range.
|
16636999
|
Rapid Commun. Mass Spectrom.
|
|
Defining the role of mass spectrometry in cancer diagnostics.
|
15466969
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.
|
11290567
|
Am. J. Pathol.
|
|
Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
|
18043497
|
Laryngoscope
|
|
Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.
|
31434495
|
Arterioscler. Thromb. Vasc. Biol.
|
|
Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques.
|
15550476
|
Clin. Chem.
|
|
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
|
15613711
|
Clin. Chem.
|
|
Expression of genes and proteins specific for prostate cancer.
|
15535438
|
J. Urol.
|
|
Feature extraction in the analysis of proteomic mass spectra.
|
16502467
|
Proteomics
|
|
Functional clustering algorithm for high-dimensional proteomics data.
|
16046812
|
J. Biomed. Biotechnol.
|
|
Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay.
|
10833385
|
Protein Expr. Purif.
|
|
Identification of patients with head and neck cancer using serum protein profiles.
|
14732777
|
Arch. Otolaryngol. Head Neck Surg.
|
|
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers.
|
16760258
|
Mol. Cell Proteomics
|
|
Measurement reproducibility in the early stages of biomarker development.
|
15665389
|
Dis. Markers
|
|
Mining the low molecular weight proteome of blood.
|
21136732
|
Proteomics Clin Appl
|
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
|
18606634
|
Clin. Chem.
|
|
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
|
12171882
|
Clin. Cancer Res.
|
|
Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.
|
17918874
|
J. Proteome Res.
|
|
Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
|
16520271
|
Urol. Oncol.
|
|
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.
|
15112261
|
Cancer
|
|
Protein profiling in urine for the diagnosis of bladder cancer.
|
15277356
|
Clin. Chem.
|
|
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.
|
12497173
|
Prostate Cancer Prostatic Dis.
|
|
Proteomic approaches to biomarker discovery in prostate and bladder cancers.
|
11721637
|
Proteomics
|
|
Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.
|
11708463
|
Ann. N. Y. Acad. Sci.
|
|
Proteomic strategies for biomarker identification: progress and challenges.
|
11249741
|
Curr. Opin. Mol. Ther.
|
|
Proteomics in early detection of cancer.
|
11568117
|
Clin. Chem.
|
|
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.
|
11507047
|
Cancer Res.
|
|
Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling.
|
16637003
|
Rapid Commun. Mass Spectrom.
|
|
SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
|
17705230
|
Prostate
|
|
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
|
15726646
|
Hepatology
|
|
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
|
18024530
|
Clin. Chem.
|
|
SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.
|
15258337
|
Dis. Markers
|
|
Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis.
|
15283892
|
Urol. Oncol.
|
|
Serum biomarkers to differentiate benign and malignant mammographic lesions.
|
17481542
|
J. Am. Coll. Surg.
|
|
Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
|
15709174
|
Clin. Cancer Res.
|
|
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
|
15258333
|
Dis. Markers
|
|
Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
|
12097261
|
Cancer Res.
|
|
Serum protein profiles to identify head and neck cancer.
|
15014013
|
Clin. Cancer Res.
|
|
Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.
|
15723595
|
Expert Rev. Mol. Diagn.
|
|
Signal detection in high-resolution mass spectrometry data.
|
18173224
|
J. Proteome Res.
|
|
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.
|
15383419
|
Ann. Surg. Oncol.
|
|
The "omics" haystack: defining sources of sample bias in expression profiling.
|
16120944
|
Clin. Chem.
|
|
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
|
15283893
|
Urol. Oncol.
|
